Table 2.
Baseline clinical, laboratory, and imaging characteristics in patients with an increased and normal MIB-I labeling index. p-values in italic and bold represent statistically significant results.
| Variable | MIB-I ≥ 6% (n = 50) | MIB-I < 6% (n = 158) | p-Value |
|---|---|---|---|
| Age (mean ± SD) | 62.8 ± 16.0 | 60.3 ± 12.8 | 0.33 |
| Sex (female/male) | 35/23 | 117/33 | 0.02 |
| KPS (mean ± SD) | 86.8 ± 14.2 | 90.4 ± 11.1 | 0.10 |
| Diabetes (yes/no) | 9/41 | 16/142 | 0.21 |
| Smoking (yes/no; available in 204 patients) | 12/38 | 43/111 | 0.31 |
| BMI (mean ± SD) | 26.8 ± 6.1 | 27.6 ± 6.2 | 0.41 |
| ASA intake (yes/no) | 5/45 | 21/137 | 0.63 |
| Dexamethasone (yes/no) | 18/32 | 40/118 | 0.15 |
| Anticonvulsant drugs (yes/no) | 12/38 | 31/127 | 0.55 |
| Hemoglobin (mean ± SD) | 14.3 ± 1.5 | 14.0 ± 1.3 | 0.27 |
| MCV (mean ± SD) | 85.8 ± 8.6 | 87.6 ± 4.9 | 0.07 |
| Platelet count (mean ± SD) | 257.6 ± 78.5 | 278.2 ± 95.5 | 0.17 |
| MPV (mean ± SD) | 10.6 ± 0.9 | 12.8 ± 22.0 | 0.48 |
| Fibrinogen (mean ± SD) | 2.5 ± 0.9 | 3.2 ± 0.8 | <0.001 |
| C-reactive protein (mean ± SD) | 1.6 ± 2.1 | 4.3 ± 9.4 | 0.001 |
| Tumor size (mean ± SD, mm) | 39.8 ± 15.2 | 32.2 ± 15.1 | 0.002 |
| Peritumoral edema (yes/no) | 35/15 | 67/91 | 0.001 |
| Sinus invasion (yes/no) | 13/37 | 31/127 | 0.43 |
| Brain invasion (yes/no; available in 206 patients) | 6/44 | 6/150 | 0.08 |